|
|
||||||||
Departments of Neurology and Neurological Sciences (Drs. Mantegazza and Steinman, and D. Mitchell), and Pharmacology (Drs. Hughes and Blau, and M. Travis), Stanford University, Stanford, CA, and Department of Neuromuscular Diseases (Dr. Mantegazza), Istituto Neurologico "C. Besta," Milan, Italy.
Some investigators have proposed myoblast transfer as a potential therapy for the treatment of Duchenne muscular dystrophy. Little is known about the immunobiology of myoblast transplantation. Transplantation rejection is mediated to a large extent by CD8+ T cells, which recognize alloantigens encoded by class IHL A genes, and by CD4+ T cells, which recognize alloantigens encoded by class II HLA genes. Gamma interferon (IFN-
) is a potent inducer of HLA class II molecules as well as ß2-microglobulin, which is co-expressed with HLA class I. IFN-
may be a critical cytokine involved in graft rejection. We purified human myoblasts by flow cytometry and incubated them in vitro for varying time periods with recombinant human IFN-
. The inducibility of HLA-DR and -DP molecules raises a note of caution concerning possible rejection phenomenon which might occur following myoblast transplantation.
Address correspondence and reprint requests to Dr. Lawrence Steinman, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305-5235.
Renato Mantegazza is a recipient of a Patty Roach Fellowship from the California Chapter of the Myasthenia Gravis Foundation, and is on leave from the Istituto Neurologico "C. Besta," Milan, Italy. Supported by grants from Smith Kline, Beckman, the National Institutes of Health, and the Muscular Dystrophy Association.
Received June 5, 1990. Accepted for publication in final form December 11, 1990.
This article has been cited by other articles:
![]() |
R. Geiben-Lynn, J. R. Greenland, K. Frimpong-Boateng, N. van Rooijen, A.-H. Hovav, and N. L. Letvin CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses Blood, December 1, 2008; 112(12): 4585 - 4590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cheng, M.-H. Nguyen, G. Fantuzzi, and T. J. Koh Endogenous interferon-{gamma} is required for efficient skeletal muscle regeneration Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1183 - C1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geiben-Lynn, J. R. Greenland, K. Frimpong-Boateng, and N. L. Letvin Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses Clin. Vaccine Immunol., April 1, 2008; 15(4): 691 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reyes-Reyna, T. Stegall, and K. A. Krolick Muscle Responds to an Antibody Reactive with the Acetylcholine Receptor by Up-Regulating Monocyte Chemoattractant Protein 1: A Chemokine with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis J. Immunol., August 1, 2002; 169(3): 1579 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Englund, E. Lindroos, I. Nennesmo, L. Klareskog, and I. E. Lundberg Skeletal Muscle Fibers Express Major Histocompatibility Complex Class II Antigens Independently of Inflammatory Infiltrates in Inflammatory Myopathies Am. J. Pathol., October 1, 2001; 159(4): 1263 - 1273. [Abstract] [Full Text] |
||||
![]() |
M. De Rossi, P. Bernasconi, F. Baggi, R. de Waal Malefyt, and R. Mantegazza Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol., September 1, 2000; 12(9): 1329 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jooss, Y. Yang, K. J. Fisher, and J. M. Wilson Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers J. Virol., May 1, 1998; 72(5): 4212 - 4223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |